Plant-made vaccines in support of the Millennium Development Goals
Open Access
- 18 January 2011
- journal article
- review article
- Published by Springer Science and Business Media LLC in Plant Cell Reports
- Vol. 30 (5), 789-798
- https://doi.org/10.1007/s00299-010-0995-5
Abstract
Vaccines are one of the most successful public health achievements of the last century. Systematic immunisation programs have reduced the burden of infectious diseases on a global scale. However, there are limitations to the current technology, which often requires costly infrastructure and long lead times for production. Furthermore, the requirement to keep vaccines within the cold-chain throughout manufacture, transport and storage is often impractical and prohibitively expensive in developing countries—the very regions where vaccines are most needed. In contrast, plant-made vaccines (PMVs) can be produced at a lower cost using basic greenhouse agricultural methods, and do not need to be kept within such narrow temperature ranges. This increases the feasibility of developing countries producing vaccines locally at a small-scale to target the specific needs of the region. Additionally, the ability of plant-production technologies to rapidly produce large quantities of strain-specific vaccine demonstrates their potential use in combating pandemics. PMVs are a proven technology that has the potential to play an important role in increasing global health, both in the context of the 2015 Millennium Development Goals and beyond.Keywords
This publication has 82 references indexed in Scilit:
- Tobacco, a highly efficient green bioreactor for production of therapeutic proteinsBiotechnology Advances, 2010
- Avian influenza pandemic preparedness: developing prepandemic and pandemic vaccines against a moving targetExpert Reviews in Molecular Medicine, 2010
- Secretory IgA-mediated protection againstV. choleraeand heat-labile enterotoxin-producing enterotoxigenicEscherichia coliby rice-based vaccineProceedings of the National Academy of Sciences of the United States of America, 2010
- Plant-made vaccine antigens and biopharmaceuticalsTrends in Plant Science, 2009
- Hydrophobin Fusions for High-Level Transient Protein Expression and Purification inNicotiana benthamianaPlant Physiology, 2009
- Dating the emergence of pandemic influenza virusesProceedings of the National Academy of Sciences of the United States of America, 2009
- Extremely High-Level and Rapid Transient Protein Production in Plants without the Use of Viral ReplicationPlant Physiology, 2008
- Plague: Past, Present, and FuturePLoS Medicine, 2008
- Rice-based mucosal vaccine as a global strategy for cold-chain- and needle-free vaccinationProceedings of the National Academy of Sciences of the United States of America, 2007
- Determining the transgene containment level provided by chloroplast transformationProceedings of the National Academy of Sciences of the United States of America, 2007